Expect growth, innovation in digital health landscape: BCG

Digital health technologies such as remote monitoring and telemedicine attendance were certainly before the pandemic. Today, however, such tools are increasingly relied on by both clinical researchers and healthcare professionals – to the extent that they are likely to appear after COVID-19 appears in our rearview mirror.

In his recent report The future of digital health: innovative health projections for 2022Boston Digital Consulting (BCG) collects forecasts from a number of experts regarding trends that may affect the industry. Outsourcing-Pharma recently tested these experts to learn about the report and what it can reveal about the current state of digital health as well as the future.

OSP: Could you tell us a little bit about how digital health has evolved (including what that phrase means to life sciences professionals) in recent years?Taking care of

BCG: The last few years have seen a significant influx of capital into the digital health market, with investment doubling every year. This influx has not only accelerated the development of technology, but has also created an opportunity for more talent to enter the market, especially talent with experience in the sector who may not have been able to jump earlier. What used to be small startups are now companies that develop enterprise-class solutions.

In particular, how do pharmaceutical companies and their research partners use digital health solutions in drug development?

The three major categories, though not exhaustive, include the following:

  • Detection of drugs based on AI / algorithmThese players often act as service providers to accelerate early research and even preclinical interventions. In some cases, companies with patented algorithms, labs, and data access have ambitions to be pharmaceutical companies themselves.
  • Clintech for clinical trial operationsClinical IT is evolving rapidly to service evolution in clinical trials such as decentralized models. New technologies, such as remote monitoring, eCOA, eConsent, telemedicine and more, are being used to change the way patients interact with sites – and both interact with sponsors. These changes allow for faster recruitment of subjects, improved interaction during testing, new endpoints through remote data collection, new ideas through digital data, and faster test time overall.
  • Data solutions that can be widely applied throughout the value chainIn recent years, medical data markets have increased through claims, EHR, labs and more. Direct access to provider systems allows better site selection and even patient identification, new analytics tools allow sponsors to engage self-care, and platform technologies such as data lakes for specific developers can open up new channels of understanding.

.

Leave a Comment